Cassava Sciences Stock Alpha and Beta Analysis
| SAVA Stock | USD 2.14 0.04 1.83% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cassava Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cassava Sciences over a specified time horizon. Remember, high Cassava Sciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cassava Sciences' market risk premium analysis include:
Beta 3.05 | Alpha (0.78) | Risk 5.83 | Sharpe Ratio (0.12) | Expected Return (0.71) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Cassava Sciences Backtesting, Cassava Sciences Valuation, Cassava Sciences Correlation, Cassava Sciences Hype Analysis, Cassava Sciences Volatility, Cassava Sciences History and analyze Cassava Sciences Performance. Cassava Sciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cassava Sciences market risk premium is the additional return an investor will receive from holding Cassava Sciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cassava Sciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cassava Sciences' performance over market.| α | -0.78 | β | 3.05 |
Cassava Sciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cassava Sciences' Buy-and-hold return. Our buy-and-hold chart shows how Cassava Sciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cassava Sciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Cassava Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cassava Sciences shares will generate the highest return on investment. By understating and applying Cassava Sciences stock market price indicators, traders can identify Cassava Sciences position entry and exit signals to maximize returns.
| Price Series Division | ||
| Price Series Multiplication | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Hanging Man | ||
| Long Line Candle |
Cassava Sciences Return and Market Media
The median price of Cassava Sciences for the period between Fri, Oct 10, 2025 and Thu, Jan 8, 2026 is 3.1 with a coefficient of variation of 21.25. The daily time series for the period is distributed with a sample standard deviation of 0.67, arithmetic mean of 3.13, and mean deviation of 0.51. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Insider Trading | 10/21/2025 |
2 | Tesla Stock Slides After EV Makers Earnings Disappoint - Barrons | 10/22/2025 |
3 | Why Cassava Sciences Inc. stock appeals to dividend investors - Market Risk Report Pattern Based Trade Signal System - newser.com | 11/04/2025 |
4 | Why global investors buy Cassava Sciences Inc. stock - 2025 Price Momentum Risk Controlled Daily Trade Plans - newser.com | 11/13/2025 |
5 | Acquisition by Richard Barry of 73385 shares of Cassava Sciences at 2.75 subject to Rule 16b-3 | 11/19/2025 |
6 | Acquisition by Anderson Robert Eugene Jr of 8600 shares of Cassava Sciences at 2.9 subject to Rule 16b-3 | 11/24/2025 |
7 | Cassava Sciences Submits IND Application for Simufilam - TipRanks | 12/03/2025 |
8 | FDA Places Clinical Hold on Cassavas Epilepsy Trial - TipRanks | 12/18/2025 |
9 | Cassava Announces Agreement to Settle Securities Class Action Litigation | 12/23/2025 |
10 | Why Cassava Sciences Inc. Equity Warrant stock remains a top recommendation - REITs Market Trends Big Gains Small Capital - ulpravda.ru | 01/07/2026 |
About Cassava Sciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cassava or other stocks. Alpha measures the amount that position in Cassava Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 2.23 | 2.21 | Price To Sales Ratio | 0.87 | 0.83 |
Cassava Sciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Cassava Sciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cassava Sciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cassava Sciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cassava Sciences. Please utilize our Beneish M Score to check the likelihood of Cassava Sciences' management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Cassava Sciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cassava Sciences Backtesting, Cassava Sciences Valuation, Cassava Sciences Correlation, Cassava Sciences Hype Analysis, Cassava Sciences Volatility, Cassava Sciences History and analyze Cassava Sciences Performance. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Cassava Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.